Synopsis of recent research by authors named "Randol Kennedy"
- Randol Kennedy's recent research focuses on the impact of immune checkpoint inhibitors (ICIs) on endocrinopathies, particularly their effects on endocrine glands such as the thyroid, highlighting their association with cancer outcomes and the differentiation from other immune-related adverse events.
- The studies underscore the increasing incidence of endocrinopathies from ICI treatment, revealing that while these inhibitors significantly extend cancer-free survival, they also bring about varied and significant toxic effects, with thyroid dysfunction being the most commonly observed.
- In addition to endocrinopathy research, Kennedy has explored barriers to effective palliative care services in acute settings, emphasizing health professionals' perspectives on recognizing and managing noncancer terminal diseases and the challenges faced in implementing timely palliative care.
